Sphingosine-1-phosphate: Boon and bane for the brain

Cellular Physiology and Biochemistry

Volumn 34, Issue 1, 2014, Pages 148-157

  Van Echten Deckert, Gerhild ^a   Hagen Euteneuer, Nadine ^a   Karaca, Ilker ^a   Walter, Jochen ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Alzheimer's disease; Amyloid beta; cis 4 methylsphingosine; FTY720 (fingolimod); Neurodegeneration; S1P lyase; Sphingosine 1 phosphate; Tau

Indexed keywords

LIPID; LYASE; PHOSPHATASE; PHOSPHOTRANSFERASE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE LYASE; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; LYSOPHOSPHOLIPID; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE; SPHINGOSINE 1-PHOSPHATE LYASE (ALDOLASE); TAU PROTEIN;

ALZHEIMER DISEASE; BRAIN DEVELOPMENT; BRAIN METABOLISM; DEGENERATIVE DISEASE; HUMAN; LIPID METABOLISM; MITOSIS; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; BRAIN; MOLECULAR PATHOLOGY; SPHINGOLIPID METABOLISM; SURVIVAL; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; DEFICIENCY; GENETICS; METABOLISM;

ALDEHYDE-LYASES; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; LYSOPHOSPHOLIPIDS; SPHINGOSINE; TAU PROTEINS;

EID: 84903955408     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000362991     Document Type: Review

References (76)

1. Simons K, Gerl MJ: Revitalizing membrane rafts: New tools and insights. Nat Rev Mol Cell Biol 2010;11:688-699.
2. Zhang Y, Li X, Becker KA, Gulbins E: Ceramide-enriched membrane domains-structure and function. Biochim Biophys Acta 2009;1788:178-183.
3. van Echten-Deckert G, Herget T: Sphingolipid metabolism in neural cells. Biochim Biophys Acta 2006;1758:1978-1994. (Pubitemid 44879360)
4. Hannun YA, Obeid LM: Principles of bioactive lipid signalling: Lessons from sphingolipids. Nat Rev Mol Cell Biol 2008;9:139-150. (Pubitemid 351158911)
5. Spiegel S, Milstien S: Sphingosine-1-phosphate: Signaling inside and out. FEBS Lett 2000;476:55-57. (Pubitemid 30394650)
6. Spiegel S, Milstien S: Sphingosine-1-phosphate: An enigmatic signalling lipid. Nat Rev Mol Cell Biol 2003;4:397-407. (Pubitemid 36565571)
7. Saba JD, Hla T: Point-counterpoint of sphingosine 1-phosphate metabolism. Circ Res 2004;94:724-734. (Pubitemid 38451733)
8. Liu Y, Wada R, Yamashita T, Mi Y, Deng CX, Hobson JP, Rosenfeldt HM, Nava VE, Chae SS, Lee MJ, Liu CH, Hla T, Spiegel S, Proia RL: Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest 2000;106:951-961.
9. Mizugishi K, Yamashita T, Olivera A, Miller GF, Spiegel S, Proia RL: Essential role for sphingosine kinases in neural and vascular development. Mol Cell Biol 2005;25:11113-11121. (Pubitemid 41747151)
10. Inoue M, Rashid MH, Fujita R, Contos JJ, Chun J, Ueda H: Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat Med 2004;10:712-718. (Pubitemid 38937636)
11. Doyle T, Chen Z, Obeid LM, Salvemini D: Sphingosine-1-phosphate acting via the S1P(1) receptor is a downstream signaling pathway in ceramide-induced hyperalgesia. Neurosci Lett 2011;499:4-8.
12. Meyer zu Heringdorf D, Liliom K, Schaefer M, Danneberg K, Jaggar JH, Tigyi G, Jakobs KH: Photolysis of intracellular caged sphingosine-1-phosphate causes Ca2+ mobilization independently of G-protein-coupled receptors. FEBS Lett 2003;554:443-449. (Pubitemid 37412529)
13. Olivera A, Spiegel S: Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature 1993;365:557-560. (Pubitemid 23317779)
14. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind S, Spiegel S: Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 1996;381:800-803. (Pubitemid 26243122)
15. Olivera A, Rosenfeldt HM, Bektas M, Wang F, Ishii I, Chun J, Milstien S, Spiegel S: Sphingosine kinase type 1 induces G12/13-mediated stress fiber formation, yet promotes growth and survival independent of G protein-coupled receptors. J Biol Chem 2003;278:46452-46460. (Pubitemid 37452217)
16. Hait NC, Allegood J, Maceyka M, Strub GM, Harikumar KB, Singh SK, Luo C, Marmorstein R, Kordula T, Milstien S, Spiegel S: Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 2009;325:1254-1257.
17. Bagdanoff JT, Donoviel MS, Nouraldeen A, Tarver J, Fu Q, Carlsen M, Jessop TC, Zhang H, Hazelwood J, Nguyen H, Baugh SD, Gardyan M, Terranova KM, Barbosa J, Yan J, Bednarz M, Layek S, Courtney LF, Taylor J, Digeorge-Foushee AM, Gopinathan S, Bruce D, Smith T, Moran L, O'Neill E, Kramer J, Lai Z, Kimball SD, Liu Q, Sun W, Yu S, Swaffield J, Wilson A, Main A, Carson KG, Oravecz T, Augeri DJ: Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders. J Med Chem 2009;52:3941-3953.
18. Hagen N, Van Veldhoven PP, Proia RL, Park H, Merrill AH Jr, van Echten-Deckert G: Subcellular origin of sphingosine 1-phosphate is essential for its toxic effect in lyase-deficient neurons. J Biol Chem 2009;284:11346-11353.
19. Hagen N, Hans M, Hartmann D, Swandulla D, van Echten-Deckert G: Sphingosine-1-phosphate links glycosphingolipid metabolism to neurodegeneration via a calpain-mediated mechanism. Cell Death Differ 2011;18:1356-1365.
20. van Echten-Deckert G, Walter J: Sphingolipids: Critical players in Alzheimer's disease. Prog Lipid Res 2012;51:378-393.
21. Couttas TA, Kain N, Daniels B, Lim XY, Shepherd C, Kril J, Pickford R, Li H, Garner B, Don AS: Loss of the neuroprotective factor sphingosine 1-phosphate early in Alzheimer's disease pathogenesis. Acta Neuropathol Commun 2014;2:9.
22. Ceccom J, Loukh N, Lauwers-Cances V, Touriol C, Nicaise Y, Gentil C, Uro-Coste E, Pitson S, Maurage CA, Duyckaerts C, Cuvillier O, Delisle MB: Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer's disease. Acta Neuropathol Commun 2014;2:12.
23. Takasugi N, Sasaki T, Suzuki K, Osawa S, Isshiki H, Hori Y, Shimada N, Higo T, Yokoshima S, Fukuyama T, Lee VM, Trojanowski JQ, Tomita T, Iwatsubo T: Bace1 activity is modulated by cell-associated sphingosine-1-phosphate. J Neurosci 2011;31:6850-6857.
24. Huang Y, Tanimukai H, Liu F, Iqbal K, Grundke-Iqbal I, Gong CX: Elevation of the level and activity of acid ceramidase in Alzheimer's disease brain. Eur J Neurosci 2004;20:3489-3497. (Pubitemid 40013558)
25. Kohama T, Olivera A, Edsall L, Nagiec MM, Dickson R, Spiegel S: Molecular cloning and functional characterization of murine sphingosine kinase. J Biol Chem 1998;273:23722-23728. (Pubitemid 28435703)
26. Liu H, Sugiura M, Nava VE, Edsall LC, Kono K, Poulton S, Milstien S, Kohama T, Spiegel S: Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J Biol Chem 2000;275:19513-19520. (Pubitemid 30441543)
27. Kajimoto T, Okada T, Yu H, Goparaju SK, Jahangeer S, Nakamura S: Involvement of sphingosine-1-phosphate in glutamate secretion in hippocampal neurons. Mol Cell Biol 2007;27:3429-3440. (Pubitemid 46685218)
28. Katsel P, Li C, Haroutunian V: Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: A shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease? Neurochem Res 2007;32:845-856. (Pubitemid 46481322)
29. Blondeau N, Lai Y, Tyndall S, Popolo M, Topalkara K, Pru JK, Zhang L, Kim H, Liao JK, Ding K, Waeber C: Distribution of sphingosine kinase activity and mRNA in rodent brain. J Neurochem 2007;103:509-517. (Pubitemid 47498013)
30. Brindley DN: Lipid phosphate phosphatases and related proteins: Signaling functions in development, cell division, and cancer. J Cell Biochem 2004;92:900-912. (Pubitemid 44264240)
31. Aguilar A, Saba JD: Truth and consequences of sphingosine-1-phosphate lyase. Adv Biol Regul 2012;52:17-30.
32. Van Veldhoven PP: Sphingosine-1-phosphate lyase. Methods Enzymol 2000;311:244-254. (Pubitemid 29512771)
33. Hannun YA, Obeid LM: The ceramide-centric universe of lipid-mediated cell regulation: Stress encounters of the lipid kind. J Biol Chem 2002;277:25847-25850. (Pubitemid 34967060)
34. Gulbins E, Kolesnick R: Raft ceramide in molecular medicine. Oncogene 2003;22:7070-7077. (Pubitemid 37386676)
35. Morita Y, Perez GI, Paris F, Miranda SR, Ehleiter D, Haimovitz-Friedman A, Fuks Z, Xie Z, Reed JC, Schuchman EH, Kolesnick RN, Tilly JL: Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med 2000;6:1109-1114.
36. Maceyka M, Payne SG, Milstien S, Spiegel S: Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim Biophys Acta 2002;1585:193-201. (Pubitemid 36096858)
37. Zhang X, Skrzypek MS, Lester RL, Dickson RC: Elevation of endogenous sphingolipid long-chain base phosphates kills saccharomyces cerevisiae cells. Curr Genet 2001;40:221-233. (Pubitemid 34036855)
38. Hung WC, Chuang LY: Induction of apoptosis by sphingosine-1-phosphate in human hepatoma cells is associated with enhanced expression of bax gene product. Biochem Biophys Res Commun 1996;229:11-15.
39. Davaille J, Li L, Mallat A, Lotersztajn S: Sphingosine 1-phosphate triggers both apoptotic and survival signals for human hepatic myofibroblasts. J Biol Chem 2002;277:37323-37330.
40. Harada J, Foley M, Moskowitz MA, Waeber C: Sphingosine-1-phosphate induces proliferation and morphological changes of neural progenitor cells. J Neurochem 2004;88:1026-1039. (Pubitemid 38199325)
41. Moore AN, Kampfl AW, Zhao X, Hayes RL, Dash PK: Sphingosine-1-phosphate induces apoptosis of cultured hippocampal neurons that requires protein phosphatases and activator protein-1 complexes. Neuroscience 1999;94:405-415. (Pubitemid 29436069)
42. Chipuk JE, McStay GP, Bharti A, Kuwana T, Clarke CJ, Siskind LJ, Obeid LM, Green DR: Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis. Cell 2012;148:988-1000.
43. Bär T, Kratzer B, Wild R, Sandhoff K, Schmidt RR: Synthesis of methyl-branched sphingosines. Liebigs Ann Chem 1993:419-426.
44. van Echten-Deckert G, Schick A, Heinemann T, Schnieders B: Phosphorylated cis-4-methylsphingosine mimics the mitogenic effect of sphingosine-1-phosphate in Swiss 3T3 fibroblasts. J Biol Chem 1998;273:23585-23589. (Pubitemid 28417552)
45. Naetzker S, Hagen N, Echten-Deckert G: Activation of p38 mitogen-activated protein kinase and partial reactivation of the cell cycle by cis-4-methylsphingosine direct postmitotic neurons towards apoptosis. Genes Cells 2006;11:269-279.
46. van Echten-Deckert G, Zschoche A, Bar T, Schmidt RR, Raths A, Heinemann T, Sandhoff K: Cis-4-methylsphingosine decreases sphingolipid biosynthesis by specifically interfering with serine palmitoyltransferase activity in primary cultured neurons. J Biol Chem 1997;272:15825-15833. (Pubitemid 27265560)
47. Allende ML, Sasaki T, Kawai H, Olivera A, Mi Y, van Echten-Deckert G, Hajdu R, Rosenbach M, Keohane CA, Mandala S, Spiegel S, Proia RL: Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J Biol Chem 2004;279:52487-52492. (Pubitemid 39656625)
48. Don AS, Martinez-Lamenca C, Webb WR, Proia RL, Roberts E, Rosen H: Essential requirement for sphingosine kinase 2 in a sphingolipid apoptosis pathway activated by FTY720 analogues. J Biol Chem 2007;282:15833-15842. (Pubitemid 47093290)
49. Natzker S, Heinemann T, Figueroa-Perez S, Schnieders B, Schmidt RR, Sandhoff K, van Echten-Deckert G: Cis-4-methylsphingosine phosphate induces apoptosis in neuroblastoma cells by opposite effects on p38 and ERK mitogen-activated protein kinases. Biol Chem 2002;383:1885-1894. (Pubitemid 36041050)
50. Doi Y, Takeuchi H, Horiuchi H, Hanyu T, Kawanokuchi J, Jin S, Parajuli B, Sonobe Y, Mizuno T, Suzumura A: Fingolimod phosphate attenuates oligomeric amyloid beta-induced neurotoxicity via increased brain-derived neurotrophic factor expression in neurons. PLoS One 2013;8:e61988.
51. Ghosh TK, Bian J, Gill DL: Sphingosine 1-phosphate generated in the endoplasmic reticulum membrane activates release of stored calcium. J Biol Chem 1994;269:22628-22635. (Pubitemid 24273370)
52. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J: Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 2000;403:98-103. (Pubitemid 30038529)
53. Lopes JP, Oliveira CR, Agostinho P: Neurodegeneration in an abeta-induced model of Alzheimer's disease: The role of CDK5. Aging Cell 2010;9:64-77.
54. Lopes JP, Oliveira CR, Agostinho P: CDK5 acts as a mediator of neuronal cell cycle re-entry triggered by amyloid-beta and prion peptides. Cell Cycle 2009;8:97-104.
55. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH: Conversion of p35 to p25 deregulates CDK5 activity and promotes neurodegeneration. Nature 1999;402:615-622. (Pubitemid 129516324)
56. Dhavan R, Tsai LH: A decade of CDK5. Nat Rev Mol Cell Biol 2001;2:749-759. (Pubitemid 33679837)
57. Lee MS, Tsai LH: Cdk5: One of the links between senile plaques and neurofibrillary tangles? J Alzheimers Dis 2003;5:127-137.
58. Selkoe D, Mandelkow E, Holtzman D: Deciphering Alzheimer disease. Cold Spring Harb Perspect Med 2012;2:a011460.
59. St George-Hyslop PH, Petit A: Molecular biology and genetics of Alzheimer's disease. C R Biol 2005;328:119-130. (Pubitemid 40247057)
60. Tanzi RE: The genetics of Alzheimer disease. Cold Spring Harb Perspect Med 2012;2: pii: a006296.
61. De Strooper B, Vassar R, Golde T: The secretases: Enzymes with therapeutic potential in Alzheimer disease. Nat Rev Neurol 2010;6:99-107.
62. Haass C, Kaether C, Thinakaran G, Sisodia S: Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med 2012;2:a006270.
63. Hartmann T, Kuchenbecker J, Grimm MO: Alzheimer's disease: The lipid connection. J Neurochem 2007;103:S159-170.
64. Walter J: Gamma-secretase, apolipoprotein E and cellular cholesterol metabolism. Curr Alzheimer Res 2012;9:189-199.
65. Puglielli L, Tanzi RE, Kovacs DM: Alzheimer's disease: The cholesterol connection. Nat Neurosci 2003;6:345-351. (Pubitemid 36373979)
66. Wood WG, Li L, Muller WE, Eckert GP: Cholesterol as a causative factor in Alzheimer's disease: A debatable hypothesis. J Neurochem 2014;129:559-572.
67. Lane RM, Farlow MR: Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease. J Lipid Res 2005;46:949-968.
68. Walter J, van Echten-Deckert G: Cross-talk of membrane lipids and Alzheimer-related proteins. Mol Neurodegener 2013;8:34.
69. Hagen-Euteneuer N, Lutjohann D, Park H, Merrill AH Jr, van Echten-Deckert G: Sphingosine 1-phosphate (S1P) lyase deficiency increases sphingolipid formation via recycling at the expense of de novo biosynthesis in neurons. J Biol Chem 2012;287:9128-9136.
70. Karaca I, Tamboli IY, Glebov K, Richter J, Fell LH, Grimm MO, Haupenthal VJ, Hartmann T, Gräler MH, van Echten-Deckert G, Walter J: Deficiency of sphingosine-1-phosphate lyase impairs lysosomal metabolism of the amyloid precursor protein. J Biol Chem 2014;289:16761-16772.
71. Jiang X, Han X: Characterization and direct quantitation of sphingoid base-1-phosphates from lipid extracts: A shotgun lipidomics approach. J Lipid Res 2006;47:1865-1873. (Pubitemid 44222838)
72. Borowsky AD, Bandhuvula P, Kumar A, Yoshinaga Y, Nefedov M, Fong LG, Zhang M, Baridon B, Dillard L, de Jong P, Young SG, West DB, Saba JD: Sphingosine-1-phosphate lyase expression in embryonic and adult murine tissues. J Lipid Res 2012;53:1920-1931.
73. Bektas M, Allende ML, Lee BG, Chen W, Amar MJ, Remaley AT, Saba JD, Proia RL: S1P lyase deficiency disrupts lipid homeostasis in liver. J Biol Chem 2010;285:10880-10889.
74. Takasugi N, Sasaki T, Ebinuma I, Osawa S, Isshiki H, Takeo K, Tomita T, Iwatsubo T: FTY720/fingolimod, a sphingosine analogue, reduces amyloid-beta production in neurons. PLoS One 2013;8:e64050.
75. Asle-Rousta M, Kolahdooz Z, Oryan S, Ahmadiani A, Dargahi L: FTY720 (fingolimod) attenuates beta-amyloid peptide (abeta42)-induced impairment of spatial learning and memory in rats. J Mol Neurosci 2013;50:524-532.
76. Hemmati F, Dargahi L, Nasoohi S, Omidbakhsh R, Mohamed Z, Chik Z, Naidu M, Ahmadiani A: Neurorestorative effect of FTY720 in a rat model of Alzheimer's disease: Comparison with memantine. Behav Brain Res 2013;252:415-421.